Notably, IFN hyperactivity is a recognized driver of type I interferonopathies, a group of monogenic disorders leading to overproduction of IFNs, as well as a range of autoinflammatory conditions, most prominently SLE (18, 19, 49). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.